Suppr超能文献

用于测定大鼠血浆中右美沙芬和右啡烷的低体积血浆采样:液相色谱-串联质谱法及其在药代动力学研究中的应用

Low-volume plasma sampling for determination of dextromethorphan and dextrorphan in rat plasma: LC-MS/MS method and its application in pharmacokinetic study.

作者信息

Majhi Praful Kumar, Sayyad Samir, Mishra Pratyush, Kamte Sainath, Sahu Rajanikant, Ghosh Goutam, Subudhi Bharat Bhusan

机构信息

School of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to be University, Bhubaneswar, India.

Synapse Labs Pvt. Ltd, Pune, India.

出版信息

Biomed Chromatogr. 2023 Apr;37(4):e5588. doi: 10.1002/bmc.5588. Epub 2023 Feb 16.

Abstract

Dextromethorphan (DM) and its metabolite dextrorphan (DX) continue to draw the attention of researchers owing to their diverse pharmacodynamics. Thus, there are possibilities for repurposing DM. Most of the pharmacodynamics of DM needs further validation in different preclinical models. Also, it is necessary to correlate the pharmacodynamics with relevant pharmacokinetics data. Multiple bioanalytical techniques developed for this purpose primarily use a high sample processing volume. Since sample volume is a limiting factor for many preclinical models, an effort was taken to develop an alternative method suitable for handling low sample processing volumes. An efficient solid-phase extraction technique, robust liquid chromatographic (LC) separation and highly sensitive tandem mass spectrometric detection (MS/MS) showed suitability for use of a 30 μl sample processing volume. This led to the development of a highly specific, selective, accurate and precise-bio-analytical method for simultaneous quantification of DM and DX in rat plasma. The validated method was linear in the range of 0.196-403.356 ng/ml for DM and 0.102-209.017 ng/ml for DX. The application of the method was demonstrated through the estimation of pharmacokinetic parameters that showed good congruence with earlier studies.

摘要

右美沙芬(DM)及其代谢物右啡烷(DX)因其多样的药效学特性持续吸引着研究人员的关注。因此,存在将右美沙芬重新用于其他用途的可能性。右美沙芬的大多数药效学特性需要在不同的临床前模型中进一步验证。此外,有必要将药效学与相关的药代动力学数据相关联。为此开发的多种生物分析技术主要使用大量的样品处理量。由于样品量是许多临床前模型的限制因素,因此人们努力开发一种适合处理少量样品处理量的替代方法。一种高效的固相萃取技术、稳健的液相色谱(LC)分离和高灵敏度的串联质谱检测(MS/MS)显示适用于30μl的样品处理量。这导致开发出一种高度特异性、选择性、准确和精确的生物分析方法,用于同时定量大鼠血浆中的右美沙芬和右啡烷。验证后的方法在右美沙芬浓度为0.196 - 403.356 ng/ml和右啡烷浓度为0.102 - 209.017 ng/ml范围内呈线性。通过估算药代动力学参数证明了该方法的应用,这些参数与早期研究显示出良好的一致性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验